Stonegate Investment Group’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$287K Sell
6,085
-1,042
-15% -$50.3K 0.01% 326
2025
Q2
$344K Buy
7,127
+863
+14% +$44.1K 0.01% 286
2025
Q1
$347K Sell
6,264
-2,544
-29% -$138K 0.01% 262
2024
Q4
$425K Buy
8,808
+57
+0.7% +$2.9K 0.01% 231
2024
Q3
$504K Buy
8,751
+3,377
+63% +$182K 0.01% 228
2024
Q2
$261K Buy
+5,374
New +$259K 0.01% 287

Other funds holding SNY

Stonegate Investment Group's SNY Position: Q3 2025 in Review

Stonegate Investment Group reduced its Sanofi (SNY) stake by 15% in Q3 2025, selling an estimated $50.3K and leaving 6,085 shares worth $287K. The position accounts for 0.01% of the portfolio, ranked #326.

Stonegate Investment Group first reported a position in SNY in Q2 2024 and has held it in 6 quarters since. The position peaked at $504K in Q3 2024. 711 funds tracked by Wall St. Rank hold SNY as of Q3 2025.

  • Stonegate Investment Group held 6,085 shares of Sanofi worth $287K as of Q3 2025.
  • Stonegate Investment Group sold 1,042 Sanofi shares in Q3 2025, an estimated $50.3K.
  • Sanofi made up 0.01% of Stonegate Investment Group's portfolio in Q3 2025, its #326 holding.
  • Stonegate Investment Group first reported a position in Sanofi in Q2 2024 and has held it in 6 quarters since.
  • Stonegate Investment Group's Sanofi position peaked at $504K in Q3 2024.
  • 711 funds tracked by Wall St. Rank held Sanofi as of Q3 2025.

Based on Stonegate Investment Group's 13F filing for Q3 2025, filed 3 Nov 2025.